Radboudumc Centre for Oncology
The university hospital of Nijmegen, a leading Dutch centre for prostate imaging, dendritic cell vaccines and tumour immunology, currently in OECI accreditation.
Overview
Radboud University Medical Center is the academic hospital of Radboud University and a tertiary cancer centre for the east of the Netherlands. Its Centre for Oncology integrates medical oncology, radiotherapy, haematology, surgical oncology and urology, and its research is internationally recognised in prostate MRI and PSMA imaging, dendritic cell vaccination and tumour immunology (Radboud Institute for Molecular Life Sciences), hereditary cancer, and hepatobiliary and pancreatic surgery. Radboudumc is listed by the Organisation of European Cancer Institutes as in accreditation.
- Prostate imaging and PSMA
- Dendritic cell vaccines
- Tumour immunology
- Hereditary cancer
Pages like this
not linked directly; found by shared links- InstitutionTurku University Hospital Cancer Centre
Shares PSMA PET, Organisation of European Cancer Institutes.
- InstitutionVejle Hospital Cancer Centre (Lillebaelt Hospital)
Shares Organisation of European Cancer Institutes, Prostate cancer.
- InstitutionTays Cancer Centre, Tampere University Hospital
Shares Organisation of European Cancer Institutes, Prostate cancer.
- CompanyClarity Pharmaceuticals
Shares PSMA PET, Prostate cancer.
- ProductFlotufolastat F-18
Shares PSMA PET, Prostate cancer.
- PersonThomas A. Hope
Shares PSMA PET, Prostate cancer.
- PersonLouise Emmett
Shares PSMA PET, Prostate cancer.
- PersonJeremie Calais
Shares PSMA PET, Prostate cancer.